Conmed Corp
CNMD44.710USD
+0.760+1.73%
Handelsschluss 11/11, 16:00（ET）Kurse um 15 Minuten verzögert
1.38BMarktkapitalisierung
21.60KGV TTM
mehr Informationen über Conmed Corp Unternehmen
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Conmed Corp Informationen
BörsenkürzelCNMD
Name des UnternehmensConmed Corp
IPO-datumJul 23, 1987
CEOMr. Patrick J. (Pat) Beyer
Anzahl der mitarbeiter3900
WertpapierartOrdinary Share
GeschäftsjahresendeJul 23
Addresse11311 Concept Boulevard
StadtLARGO
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl33773
Telefon17272142974
Websitehttps://www.conmed.com/
BörsenkürzelCNMD
IPO-datumJul 23, 1987
CEOMr. Patrick J. (Pat) Beyer
Führungskräfte von Conmed Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.13K
+18.20%
Mr. Kim Kelderman
Mr. Kim Kelderman
Independent Director
Independent Director
--
--
Mr. Richard Glaze
Mr. Richard Glaze
Chief Information Officer
Chief Information Officer
--
-100.00%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
Nach RegionUSD
Name
Umsatz
Anteil
United States
190.61M
55.68%
Europe & Middle East & Africa
63.92M
18.67%
Asia Pacific
42.07M
12.29%
Americas (excluding the United States)
31.88M
9.31%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
Aktionärsstatistik
Aktualisiert: Fri, Sep 26
Aktualisiert: Fri, Sep 26
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.30%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.14%
Fuller & Thaler Asset Management Inc.
5.62%
Capital Research Global Investors
5.41%
Andere
53.90%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.30%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.14%
Fuller & Thaler Asset Management Inc.
5.62%
Capital Research Global Investors
5.41%
Andere
53.90%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
65.04%
Investment Advisor/Hedge Fund
42.43%
Hedge Fund
4.59%
Research Firm
3.29%
Pension Fund
1.91%
Bank and Trust
0.68%
Individual Investor
0.59%
Sovereign Wealth Fund
0.06%
Venture Capital
0.05%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
643
36.52M
117.92%
-5.77M
2025Q2
651
35.90M
115.99%
-5.38M
2025Q1
664
36.95M
119.42%
-4.31M
2024Q4
649
36.65M
118.59%
-2.95M
2024Q3
644
35.57M
115.39%
-3.57M
2024Q2
660
37.07M
120.35%
-1.36M
2024Q1
657
36.04M
117.06%
-2.92M
2023Q4
642
36.87M
119.89%
-1.61M
2023Q3
624
36.40M
118.42%
-2.31M
2023Q2
606
36.19M
118.37%
-3.41M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
4.43M
14.3%
-133.34K
-2.92%
Jun 30, 2025
The Vanguard Group, Inc.
3.54M
11.44%
+42.41K
+1.21%
Jun 30, 2025
EARNEST Partners, LLC
2.83M
9.14%
+30.22K
+1.08%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.74M
5.62%
+566.60K
+48.26%
Jun 30, 2025
Capital Research Global Investors
1.68M
5.41%
+2.76K
+0.16%
Jun 30, 2025
Managed Account Advisors LLC
1.38M
4.47%
+103.77K
+8.11%
Jun 30, 2025
State Street Investment Management (US)
1.29M
4.18%
-8.83K
-0.68%
Jun 30, 2025
Westwood Management Corp. (Texas)
1.24M
4%
-484.00
-0.04%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.08M
3.5%
+184.21K
+20.50%
Jun 30, 2025
Macquarie Investment Management
969.64K
3.13%
+16.21K
+1.70%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Thu, Nov 6
Aktualisiert: Thu, Nov 6
Name
Anteil
SPDR S&P Health Care Equipment ETF
1.46%
ROBO Global Healthcare Technology & Innovation ETF
1.14%
Invesco S&P SmallCap Health Care ETF
0.93%
Harbor Human Capital Factor US Small Cap ETF
0.59%
VictoryShares Small Cap Free Cash Flow ETF
0.35%
iShares US Small Cap Value Factor ETF
0.34%
First Trust Small Cap Value AlphaDEX Fund
0.3%
WisdomTree US SmallCap Quality Dividend Growth
0.26%
Lattice Hartford Multifactor Small Cap ETF
0.23%
Royce Quant Small-Cap Quality Value ETF
0.23%
Mehr Anzeigen
SPDR S&P Health Care Equipment ETF
Anteil1.46%
ROBO Global Healthcare Technology & Innovation ETF
Anteil1.14%
Invesco S&P SmallCap Health Care ETF
Anteil0.93%
Harbor Human Capital Factor US Small Cap ETF
Anteil0.59%
VictoryShares Small Cap Free Cash Flow ETF
Anteil0.35%
iShares US Small Cap Value Factor ETF
Anteil0.34%
First Trust Small Cap Value AlphaDEX Fund
Anteil0.3%
WisdomTree US SmallCap Quality Dividend Growth
Anteil0.26%
Lattice Hartford Multifactor Small Cap ETF
Anteil0.23%
Royce Quant Small-Cap Quality Value ETF
Anteil0.23%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
119.19M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Feb 25, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 04, 2025
Mar 14, 2025
Dec 10, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024
Dec 20, 2024
Jan 03, 2025
Dec 20, 2024
Aug 09, 2024
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 04, 2024
Sep 16, 2024
May 22, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 26, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Dec 05, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023
Dec 18, 2023
Jan 05, 2024
Dec 15, 2023
Aug 10, 2023
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 05, 2023
Sep 14, 2023
May 24, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 05, 2023
Jun 14, 2023
Feb 27, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 05, 2023
Mar 14, 2023
Dec 05, 2022
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2023 going ex on Dec 15, 2022
Dec 16, 2022
Jan 05, 2023
Dec 15, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
